Company Dynamic

ContextLogic has agreed to acquire gChem for an enterprise value of $850 million, gaining a vertically integrated portfolio of high-purity DMSO, DMS and NTO products serving pharmaceuticals, semiconductors and aerospace.

• ContextLogic gChem Deal
• DMSO Market
• Specialty Sulfur Chemicals
• Chemical Mergers Acquisitions
• High Purity Chemicals

Ineos has exited its Tianjin petrochemical joint venture with Sinopec, less than three years after its establishment. The exit agreement requires Ineos to pay Sinopec $120 million in 24 monthly installments starting March 2027. The Tianjin Nangang ethylene project, a key national initiative, will now be wholly owned by Sinopec. Ineos attributed its departure to China's persistently weak market, citing overcapacity and squeezed profit margins. Despite this, Ineos maintains its ABS venture in Ning

• Ineos
• Sinopec

Evonik’s Q2 adjusted EBITDA rose 24% to EUR 630 million, supported by supply chain disruptions and cost improvements, while structural challenges such as overcapacity and weak demand persist.

• Evonik Q2 Results
• Specialty Chemicals
• European Chemicals
• Supply Chain Disruption
• Chemical Industry Trends

Lenzing Group has announced a major global restructuring that will cut around 2,000 jobs by 2027. The Austrian fiber maker will close its Heiligenkreuz plant by the end of 2026 and its Grimsby facility by 2027, eliminating roughly 135,000 tons of annual lyocell capacity. The company is also preparing to sell its Indonesian viscose operation.CEO Georg Casperkovitz cited high European energy and labor costs as the reason for the closures. The strategy, called "Grow Nonwovens, Reset Textiles," shif

• LenzingGroup
• FineChemicals

Dafeng Haijianuo Pharmaceutical has launched a RMB 246 million technical revamp and expansion at its existing site in the Dafeng Port Petrochemical New Materials Industrial Park. The two-phase project runs from August 2026 through May 2028, adding capacity across vitamins, pharmaceutical excipients, and active ingredients. New lines include Vitamin K1, SNAC, plant-derived cholesterol, and labetalol hydrochloride, alongside expanded production of Vitamin D3, folic acid, and selenium disulfide. As

• DafengHaijianuo
• Vitamin
• APIs
• Pharmaceuticalexcipients

BASF’s approval of a EUR 1 billion share buyback program highlights the chemical giant’s shift toward capital discipline and shareholder returns amid ongoing industry restructuring and weak market conditions.

• BASF Share Buyback
• Chemical Industry Finance
• European Chemicals
• Capital Discipline
• Industrial Restructuring

Wanhua Chemical has received official approval for the environmental impact assessment of its new 240,000-ton/year iron phosphate project in Penglai, Shandong. With a total investment of approximately RMB 1.5 billion, the project has now entered the construction phase.This initiative reinforces Wanhua's strategy of positioning battery materials as its second core business. The company is rapidly expanding its lithium iron phosphate capacity across Shandong, with projects in Haiyang and Laizhou s

• WanhuaChemical
• IronPhosphate

China Resources Double-Crane Pharmaceutical has announced a major asset acquisition, planning to purchase a 23.50% stake in Lier Chemical for RMB 5.656 billion in cash. This move will transfer control of Lier Chemical from Jiuyuan Group to CR Double-Crane, with China Resources becoming the new actual controller.The acquisition bridges the pharmaceutical and pesticide sectors, driven by CR Double-Crane's ambition to scale its synthetic biology technology. While CR Double-Crane has developed biope

• Double-Crane
• LierChemical

Supply disruptions have temporarily supported BASF’s Ludwigshafen operations, but the workforce falling below 30,000 underlines the depth of the site’s long-term restructuring.

• BASF Ludwigshafen
• Plant Utilization
• Workforce Reduction
• European Chemicals
• Chemical Restructuring

Huntsman issued two regional price adjustment notices in late July, raising MDI product prices in Europe, Africa, the Middle East, and the Indian subcontinent. In Europe, Africa, and the Middle East, MDI prices increased by €250 per ton, effective August 1, 2026. This follows previous hikes of €350 per ton in December 2025 and a €200 natural gas surcharge in March 2026, totaling over €800 per ton in the past year. Huntsman cited geopolitical tensions, rising raw material and energy costs as driv

• Huntsman
• FineChemical
• MDI

Dover’s acquisition of Cloeren adds T-dies and feedblocks to MAAG’s pumps, filtration, pelletizing and recycling portfolio, moving the business closer to providing complete polymer-extrusion solutions.

• Dover
• Cloeren
• polymer extrusion
• plastics equipment
• industrial acquisition

Croda’s first-half organic sales rose 4.6% while adjusted operating profit increased 6.7%, with 19% growth in Beauty Actives making high-value Consumer Care ingredients the principal earnings driver.

• Croda
• beauty actives
• specialty chemicals
• consumer care
• half year results

GACL’s newly approved ₹550 million HCl unit at Dahej is designed to improve chlorine utilization and supply feedstock to the company’s planned phosphoric-acid operation.

argenx is paying approximately $2.2 billion for Forte Biosciences and its anti-CD122 antibody FB102, placing a major bet on a multi-indication autoimmune-disease platform.

• argenx
• Forte Biosciences
• FB102
• autoimmune antibody
• biopharma acquisition

In late July, Italian nylon producer RadiciGroup announced a restructuring plan for its Novara site, operated by subsidiary Radici Chimica. The plan involves shutting down three key chemical units—adipic acid, nitric acid, and MAB—essential for PA66 production. The facility employs up to 300 people, and the cuts will affect 140 jobs, nearly half the workforce. After three consecutive years of heavy losses, the company cited intense competition from low-cost Asian capacity, high European energy c

• RadiciGroup
• PA66
• Nylon

Hormuz-related polyethylene shortages and more than $1.3 billion in cost benefits helped Dow swing from an $801 million loss to an $802 million profit, but declining volumes show that a genuine demand recovery remains absent.

• Dow
• polyethylene prices
• Hormuz crisis
• chemical earnings
• cost reduction

Türkiye’s DAPEK cluster has attracted more than $3 billion in investment, with a 472,500-ton polypropylene plant designed to replace 17% of domestic demand and reshape eastern Mediterranean polymer trade through Algerian feedstock and Ceyhan port infrastructure.

• Türkiye petrochemicals
• polypropylene capacity
• DAPEK cluster
• import substitution
• petrochemical investment

Argentina’s $2.7 billion fertilizer project, supported by a €1.3 billion engineering contract, will add 2.1 million tons of urea capacity and convert Vaca Muerta gas into domestic supply and a new regional export business.

• Argentina urea project
• fertilizer investment
• urea capacity
• Tecnimont
• Latin America fertilizers

AstraZeneca’s $1.5 billion Zegfrovy deal gives it a commercially validated Chinese lung cancer drug and strengthens its EGFR portfolio, while demonstrating that China’s biotech industry is increasingly exporting globally approved assets rather than early-stage research projects.

• AstraZeneca
• Dizal Pharmaceutical
• Zegfrovy
• lung cancer drug
• China biotech

Oral Wegovy gives Novo Nordisk the first approved GLP-1 weight-loss pill in the EU, but its commercial impact will depend on reimbursement, manufacturing capacity and whether patients prefer daily tablets to weekly injections.

• Novo Nordisk
• oral Wegovy
• GLP1 drugs
• weight loss market
• EU approval